Introduction
============

Changes in biological rhythm are among the various characteristics of bipolar disorder (BD) and have long been associated with the functional impairment of the disease,[@b1-prbm-7-167] with damages that may persist even during remission, such as subsyndromic symptoms and risk of relapse.[@b2-prbm-7-167] These changes occur mainly due to sleep disturbances[@b3-prbm-7-167] (that can be related to allelic mutations on clock genes[@b4-prbm-7-167]), changes in routine,[@b1-prbm-7-167] and stressful life events.[@b5-prbm-7-167] It has also been suggested that bipolar subjects secrete abnormal levels of melatonin and are hypersensitive to light, which can affect their sleep patterns.[@b6-prbm-7-167] Disruptions in the biological rhythm of subjects with BD can trigger acute episodes; for example, there are clear links between sleep disturbances and mania.[@b7-prbm-7-167] A poor repertoire of coping skills to face social rhythm disruptions may compromise the maintenance of a euthymic state of the subjects, resulting in a series of failed attempts of regulation.

Although pharmacotherapy is an indispensable primary option for the treatment of BD, it is interesting to offer viable options of psychosocial interventions in order to improve pharmacological treatment adherence, coping skills, and the patient's quality of life.[@b8-prbm-7-167] These interventions are increasingly recognized as an essential component in the treatment of BD.[@b9-prbm-7-167],[@b10-prbm-7-167] Successful psychosocial interventions for unipolar depression such as adjunctive family therapy,[@b11-prbm-7-167],[@b12-prbm-7-167] cognitive behavioral therapy,[@b13-prbm-7-167] and interpersonal and social rhythm therapy[@b14-prbm-7-167] were adapted for BD and evaluated by trials, and are associated with greater symptom stabilization and change of habits. However, not all are equally effective, and the long-term effects do not indicate a significant improvement over conventional therapy.

Among all psychosocial interventions, psychoeducation (PE) has been one of the most used and is recommended by several guidelines[@b15-prbm-7-167],[@b16-prbm-7-167] as a first choice for BD due to its appeal to a wider population and because of its straightforward and cost-effective profile. PE is recommended for pharmacological adherence enhancement, knowledge, and awareness of the disease.[@b17-prbm-7-167] It is particularly helpful for subjects to learn how to detect prodromal signs of the disease and, consequently, to prevent relapses.[@b18-prbm-7-167],[@b19-prbm-7-167] Although PE is an intervention model that has been used by practitioners for some time, only recently have studies with reliable methodology shown its efficacy in clinical practice.[@b20-prbm-7-167]--[@b23-prbm-7-167] A recent systematic review by Batista[@b24-prbm-7-167] identified a total of 13 randomized clinical trials evaluating PE in BD. Briefly, these studies evaluated PE in different samples (BD-only subject, relatives/caregivers, or both), both in groups and individually. The number of sessions ranged from five to 21 meetings, and the follow-ups ranged from 6 months to 5 years. The results of the review indicate that PE is an intervention particularly effective in decreasing the relapse rate (both manic and depressive) and in improving overall social functioning. However, as pointed out by the authors, the mechanism of action of PE remains unknown. Their primary hypothesis states that teaching lifestyle regularity is the main aspect and may play a role in relapse prevention due to early detection of prodromal symptoms.

BD is a neuroprogressive disease, longitudinally associated with increased severity and an accelerated disability. One of the concepts that attempts to explain why BD worsens over time is allostatic load (AL). AL discusses the cumulative effects of an overload of the adaptative systems due to the typical chronic overactivity of the disease.[@b25-prbm-7-167] The AL increases progressively as stressors and mood episodes occur over time, and is connected to the cognitive impairment of BD, which includes attention, executive function, and verbal memory.[@b26-prbm-7-167]

Since the first mood episodes are happening earlier (the typical age of onset is 23 years) and severe symptoms are unfolding earlier, there is a possibility of higher severity of BD in younger generations.[@b27-prbm-7-167] We wondered whether a psychosocial intervention applied in younger patients, who have a shorter disease duration, fewer mood episodes, and reduced cognitive impairment, can have a different impact on regulating their biological rhythms. For this purpose, we carried out a study with young adults, aged between 18--29 years, diagnosed with BD, in which we compared a standard intervention (pharmacological with mood stabilizers) and a combined intervention of drugs and a short-term PE model.[@b28-prbm-7-167] Although studies that showed the effectiveness of PE for the treatment of BD[@b18-prbm-7-167],[@b29-prbm-7-167] had a similar design (randomized clinical trial), the sampling and the intervention design were significantly different. We do not know of any study that has evaluated a short-term individual PE intervention for bipolar subjects in a sample formed exclusively of young adults with no previous treatment.

Aim
===

The aim of this study was to assess if subjects undergoing psychosocial intervention in addition to a pharmacological treatment could have better regulation of their biological rhythms than those who were only using medication.

Method
======

Design and setting
------------------

This study is a randomized clinical trial that evaluated the influence of PE on regulating the biological rhythm of individuals with Bipolar II Disorder by comparing a standard medication intervention to an intervention combined with drugs and PE. The project was approved by the Ethics Committee on Research of Catholic University of Pelotas (UCPel), according to protocol No 2009/24, and all participants signed the informed consent.

In order to ensure the necessary sample size to estimate the effectiveness of the interventions, the trial was advertised in public health care units, psychosocial care centers, outpatient clinics, and city hospitals. The subjects recruited in these places were selected as follows. Those who agreed to participate were evaluated by a semi-structured clinical interview (SCID-I \[Structured Clinical Interview for DSM Disorders\]) in order to ensure diagnostic reliability. This interview model is based on the *Diagnostic and Statistical Manual of Mental Disorders* 4th Edition -- Text Revision, with a translation and adaptation to Portuguese that presents, in general, good reliability, with an excellent Kappa coefficient (0.87) for mood disorders.[@b30-prbm-7-167] The interviews were conducted by two PhD students, who underwent intensive training under the supervision of a senior researcher. After the bipolar II diagnosis was validated, the subjects were referred to the psychiatric services of the public health system. However, due to the difficulty in obtaining medication in the public health system in the city of Pelotas, a city in southern Brazil with a population of 350,000, a psychiatrist had to be assigned to the research team and the subjects were referred to the psychiatric outpatient clinic of the Health Campus of UCPel. The medicated subjects that matched the inclusion criteria (aged between 18--29 years, a validated clinical diagnosis of bipolar II according to SCID, and gave their informed consent) were invited to participate in the trial. Those with suicide risk and/or using illegal drugs were not included and were offered treatment at a specialized outpatient facility. The Economic Index was assessed with the National Economic Index,[@b31-prbm-7-167] based on the total of material goods and the householders' schooling, among other items. The socioeconomic classes were divided into three levels (high, intermediate, and low) for the Brazilian population according to the 2000 Demographic Census.

Outcome measures
----------------

The severity of depressive symptoms was measured with the Hamilton Depression Rating Scale, a 17-item scale that enables the creation of a discrete variable, in which the higher scores correspond to a higher severity of the symptoms. The internal consistency ranges from 0.83 to 0.94. The scale reliability between raters has been consistent in several studies.[@b32-prbm-7-167] To assess the intensity of manic symptoms, we utilized the Young Mania Rating Scale, an eleven-item scale chosen for its high reliability in measuring severity levels of mania and validity coefficient. The Brazilian validated version,[@b33-prbm-7-167] which has an even better reliability level than the original, had its internal consistency assessed by Cronbach's α, calculated using analysis of variance applied to the eleven items of the scale. From the resulting covariance matrix, α =0.67 was obtained for the scale as a whole, and α =0.72 for each standardized item (*P*\<0.001).

The evaluation of the biological rhythm was made using the Biological Rhythm Interview of Assessment in Neuropsychiatry (BRIAN). This scale was designed to offer a reliable, validated, and standardized measure of biological rhythm, with scores clinically understandable for researchers. The 18 items are divided in four specific areas (sleep, activity, social rhythm, and eating pattern) that are rated using a four-point scale: 1 (no difficulty) to 4 (very difficult). The validity and reliability of the Portuguese BRIAN version are described by Giglio et al,[@b34-prbm-7-167] including information about its factor analysis and how the areas were selected. All the outcome measures were assessed in two different time points: baseline and postintervention.

Randomization
-------------

Participants were randomly divided into two groups using sealed envelopes: one group received a short-term PE model[@b28-prbm-7-167] and medication (combined intervention), and the other received only medication (standard intervention). The randomization was made by a team member who did not participate in any of the previous stages of the study. Those who administered the intervention were not blind as to the absence or presence of PE associated with drug intervention. However, blinding of the baseline and postintervention evaluators was guaranteed (they were always blinded to subject allocation) by changing the team for each evaluation time point.

Interventions
-------------

The standard intervention was pharmacological treatment with mood stabilizers. The subjects assigned to the standard intervention followed the treatment prescribed by psychiatrists (from the public health system or the research team) according to their needs. The combined intervention consisted of medication and a short-term PE model adapted from the *Psychoeducation Manual for Bipolar Disorder* developed by Colom and Vieta.[@b28-prbm-7-167] The model was summarized in a protocol of six individual sessions of 1 hour each. Generally, the sessions occurred in the following order: the first introduced the therapist to the patient and explained the treatment guidelines, confidentiality issues, the PE protocol ("What is it" and "What it is not"), and the general concepts of BD ("What is mood?"). The second session explained the biological nature of BD, mania and hypomania concepts, and the social stigma related to the disease in order to modify inadequate understanding and feelings of guilt. The third session involved depressive symptoms, and the fourth instructed the patient to detect warning signs of recurrence (through the identification of prodromal behaviors) and the benefits of doing so (developing a predefined action plan with techniques and resources). The fifth session provided the patient with options of what to do when an episode was detected, emphasizing the importance of adherence to pharmacological treatment and contact with the psychiatrist, The sixth and final session summarized everything that was explained in the previous sessions, reinforcing aspects with which the patient had difficulty. The intervention was carried out by psychology undergraduates (in their final year) who were trained and supervised by a qualified and experienced researcher.

Regarding the pharmacological treatment in both groups, primarily only medication provided by the Brazilian Public Health System was prescribed, in order to facilitate the continuity of treatment after the end of the study. Lithium was the most commonly used medication, and was prescribed alone or in combination with other drugs such as anticonvulsants, antidepressants, neuroleptics, and benzodiazepines, according to the needs of each patient. There were no statistically significant differences between groups for the use of medication, combined or not.

Statistical analysis
--------------------

After coding the baseline and postintervention assessment tools, data were entered twice in the Epi-Info 6.04d software (Centers for Disease Control and Prevention, Atlanta, GA, USA) with consistency checked using the validate command. After that, the data were transferred to SPSS 13.0 software (IBM Corporation, Armonk, NY, USA) for statistical analyses, which is presented in three tables. [Table 1](#t1-prbm-7-167){ref-type="table"} describes the characteristics of the sample (baseline) between the two intervention groups. The data are presented in absolute and relative frequencies for qualitative variables with chi-square tests for differences between groups. Quantitative variables are described as mean and standard deviation, since they were normally distributed in the Gaussian curve. The difference between means was verified by *t*-test. [Table 2](#t2-prbm-7-167){ref-type="table"} shows, by paired *t*-test, the difference between the mean and confidence interval of the difference in symptom scores and biological rhythm of the baseline and postintervention presented in the whole group, the standard intervention group, and the combined intervention group. We also present the effect sizes of each of the associations studied.

In [Table 3](#t3-prbm-7-167){ref-type="table"}, linear regression was used to verify the difference between the remission scores of depressive and manic symptoms, as well the biological rhythm regulation between the proposed intervention groups. In the same table we can observe the coefficient of linear regression and the confidence interval of 95%, both crude and adjusted for economic index. The data shown refer to the combined intervention, using the standard intervention as reference. For all the statistical tests, significant associations were considered at a 95% significance level (*P*\<0.05).

Participants
------------

A total of 282 young adults were tested for inclusion in the trial. Among these, 220 did not meet the criteria and were referred to the Public Health System. The sample at this point consisted of 61 bipolar II subjects, 29 for standard intervention and 32 for combined intervention. During the study, there were 14 losses to follow-up (three from standard intervention and eleven from combined intervention). In addition, one patient refused to take part in the PE and another was excluded from the study due to illicit substance abuse during the PE period. Therefore, the final sample consisted of 45 individuals (26 for standard intervention and 19 for combined intervention) ([Figure 1](#f1-prbm-7-167){ref-type="fig"}). The participants were recruited between July 2010 and June 2012, and the final evaluations took place from November 2010 to September 2012.

Results
=======

In this sample, the majority of the participants were women, with an average age of 24 years, and 12 years of schooling. Randomization was effective and the distribution was homogeneous in all respects except the economic index, which showed significant difference between groups (*P*=0.041). Although the groups were similar as to the presence of symptoms at baseline, the social domain (*P*\<0.001) and the total score (*P*=0.040) of the BRIAN scale were different between groups. Other baseline information is described in [Table 1](#t1-prbm-7-167){ref-type="table"}.

Regarding the influence of the interventions on mood symptoms, according to the intention-to-treat analysis (n=61), both groups showed remission of depressive symptoms (standard *P*=0.006; combined *P*=0.041), but none showed a statistically significant reduction of manic symptoms. Unlike we expected, there was no statistically significant influence of PE on biological rhythm between the evaluations. Only the standard intervention group showed improvement in the BRIAN domains: sleep (*P*=0.012), activity (*P*\<0.001), social rhythm (*P*=0.002) and total score (*P*=0.001). All significant associations presented effect sizes between moderate and strong ([Table 2](#t2-prbm-7-167){ref-type="table"}). There was no difference in depressive symptoms remission among intervention models after the linear regression. On the other hand, there was a tendency of manic symptoms remission in the combined intervention model after adjustment for economic index (*P*=0.061). However, a strong biological rhythm regulation was found in the standard intervention group (when compared to combined), regardless of the setting ([Table 3](#t3-prbm-7-167){ref-type="table"}).

Discussion and methodological considerations
============================================

The results showed that, in this sample and time period evaluated, the combined treatment of medication and PE had no statistically significant impact on the regulation of biological rhythm when compared to standard pharmacological treatment. As the hypothesis investigated was not confirmed, despite the methodological precision in which the study was conducted, relevant research questions emerge for future studies. The economic status, for example, which was relevant mainly in the combined intervention group, has a described negative effect on the response to PE intervention.[@b35-prbm-7-167]

The sample size, a limitation of our study, reflects the struggle in finding bipolar subjects willing to enter an investigation when it was not part of a service in which they already participate. A possible reason for this is that because those subjects had only few episodes, they were not yet aware of the importance of treatment. Two other limitations of the study should be noted: the lack of control of the medication used in the standard intervention and a need for emphasis on the importance of a life routine of the subjects on the PE model. While these limitations may have influenced the study in some way, we believe, especially in the medication issue, that the success of randomization has dissipated the effects.

How PE works is worth questioning. In this particular case, when the subjects answered the questionnaires after the intervention, the PE may have helped them to become more sensitive in detecting warning signs and more self-demanding in their answers, which is common in mania and hypomania,[@b19-prbm-7-167] and consequently, lower scores were obtained. Also, the treatment duration, time period evaluated, and number of sessions probably played a key role in the results obtained. Experimental evidence shows that compact models can be effective;[@b36-prbm-7-167] however, there is a study design similar to ours[@b35-prbm-7-167] which confirms that 16 sessions (more than twice the number used in this study) did not obtain any changes. Maybe the results we obtained were not because of the number of sessions, but considering PE characteristics, that the effect happens over time and may appear in follow-up evaluations. In this sense, its longitudinal effectiveness in prophylaxis has already been proven.[@b37-prbm-7-167]

Conclusion
==========

Although the changes in biological rhythm were not statistically significant during the time period evaluated in this study, it is noteworthy that the trajectory of the score showed a trend towards improvement, which may indicate a contribution even though it may take a longer time to appear than expected. PE is an active component of successful psychosocial interventions for BD,[@b38-prbm-7-167]--[@b40-prbm-7-167] but models need to be studied and adjusted pragmatically. Other strategies must be considered, such as neuropsychological rehabilitation and social skill training, in order to build a more solid treatment combination. Some interventions do not produce the expected results, perhaps due to the design chosen (possibly the topics chosen for the PE played a key role here) or to the uncontrolled variables regarding psychotherapy research. Nonetheless, we can say that PE is not only welcome in the group of psychosocial interventions offered to bipolar subjects, but is an indispensable tool in the treatment of BD.
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###### 

Baseline demographic and clinical characteristics of each group

  Demographic and clinical characteristics                    Standard intervention n=29   Combined intervention n=32   *P*-value
  ----------------------------------------------------------- ---------------------------- ---------------------------- -----------
  Sex                                                                                                                   0.768
   Female                                                     21 (72.4%)                   21 (65.6%)                   
   Male                                                       8 (27.6%)                    11 (34.4%)                   
  Age (years)                                                 24.03 (±3.57)                24.09 (±3.90)                0.951
  Education (years)                                           12.30 (±3.33)                11.64 (±3.13)                0.467
  Economic index[\*](#tfn1-prbm-7-167){ref-type="table-fn"}                                                             0.041
   Low                                                        6 (35.3%)                    11 (64.7%)                   
   Intermediate                                               9 (50.0%)                    9 (50.0%)                    
   High                                                       12 (70.6%)                   5 (29.4%)                    
  Years of illness                                            5.48 (±4.26)                 5.06 (±4.26)                 0.702
  Current episode                                                                                                       0.466
   Euthymia                                                   2 (6.9%)                     2 (6.3%)                     
   Depression                                                 17 (18.6%)                   18 (56.3%)                   
   Hypomania                                                  1 (3.4%)                     2 (6.3%)                     
   Mania                                                      1 (3.4%)                     5 (15.6%)                    
   Mixed                                                      8 (27.6%)                    5 (15.6%)                    
  Depressive symptoms (HDRS)                                  13.07 (±6.22)                12.22 (±5.96)                0.589
  Manic symptoms (YMRS)                                       5.83 (±6.58)                 7.03 (±8.63)                 0.541
  Biological rhythm (BRIAN)                                   47.43 (±9.46)                44.84 (±11.63)               
   Sleep                                                      14.38 (±3.24)                13.81 (±6.45)                0.662
   Activity                                                   12.86 (±3.88)                11.16 (±3.62)                0.082
   Social rhythm                                              10.69 (±2.20)                8.56 (±1.81)                 \<0.001
   Eating                                                     11.07 (±2.85)                9.97 (±3.58)                 0.193
   Total                                                      49.00 (±8.78)                43.50 (±11.55)               0.040

**Note:**

Missing data in this category.

**Abbreviations:** BRIAN, Biological Rhythm Interview of Assessment in Neuropsychiatry; HDRS, Hamilton Depression Rating Scale; YMRS, Young Mania Rating Scale.

###### 

Outcome results for each group

  Outcomes                       Postintervention   Differences between means baseline (95%CI)   *P*-value                                            Effect size *r*
  ------------------------------ ------------------ -------------------------------------------- ---------------------------------------------------- -----------------
  Total sample                                                                                                                                        
   Depression symptoms           12.57 (±5.79)      2.59 (1.16; 4.02)                            0.001[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.424
   Manic symptoms                5.11 (±5.18)       1.34 (−0.72; 3.41)                           0.198                                                0.167
   Biological rhythm                                                                                                                                  
    Sleep                        12.82 (±3.58)      1.26 (−0.17; 2.70)                           0.083                                                0.222
    Activity                     9.87 (±3.36)       2.10 (0.82; 3.38)                            0.002[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.390
    Social rhythm                8.82 (±2.58)       0.75 (−0.04; 1.54)                           0.061                                                0.239
    Eating                       9.66 (±3.57)       0.84 (−0.31; 1.98)                           0.150                                                0.185
    Total                        41.16 (±9.17)      4.95 (1.24; 8.66)                            0.010[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.326
  Standard intervention (n=29)                                                                                                                        
   Depression symptoms           12.62 (±5.49)      3.55 (1.09; 6.01)                            0.006[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.487
   Manic symptoms                5.62 (±4.40)       0.21 (−2.88; 3.30)                           0.892                                                0.026
   Biological rhythm                                                                                                                                  
    Sleep                        12.17 (±3.62)      2.21 (0.52; 3.89)                            0.012[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.451
    Activity                     9.41 (±3.41)       3.45 (1.66; 5.23)                            \<0.001[\*](#tfn3-prbm-7-167){ref-type="table-fn"}   0.599
    Social rhythm                8.62 (±2.87)       2.07 (0.84; 3.30)                            0.002[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.545
    Eating                       9\. 62 (±3.71)     1.45 (−0.15; 3.05)                           0.074                                                0.331
    Total                        39.83 (±9.18)      9.17 (4.04; 14.31)                           0.001[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.569
  Combined intervention (n=32)                                                                                                                        
   Depression symptoms           12.53 (±6.14)      1.72 (0.07; 3.36)                            0.041[\*](#tfn3-prbm-7-167){ref-type="table-fn"}     0.357
   Manic symptoms                4.66 (±5.82)       2.37 (−0.50; 5.25)                           0.102                                                0.289
   Biological rhythm                                                                                                                                  
    Sleep                        13.41 (±3.49)      0.41 (−1.91; 2.72)                           0.723                                                0.064
    Activity                     10.28 (±3.31)      0.87 (−0.93; 2.68)                           0.330                                                0.175
    Social rhythm                9.00 (±2.33)       −0.44 (−1.31; 0.44)                          0.315                                                0.180
    Eating                       9.69 (±3.49)       0.28 (−1.41; 1.98)                           0.738                                                0.060
    Total                        42.38 (±9.14)      1.12 (−4.10; 6.35)                           0.664                                                0.079

**Note:**

*P*-value \<0.05

**Abbreviation:** CI, confidence interval.

###### 

Crude and adjusted linear regression for symptoms remission and biological rhythm regulation comparisons between intervention groups

  Outcomes                       Crude                    Adjusted for economic index                            
  ------------------------------ ------------------------ ----------------------------- ------------------------ -------
  Depression symptom remission                                                                                   
   Combined intervention         −1.07 (−4.91; 2.77)      0.578                         −1.86 (−6.34; 2.61)      0.404
  Manic symptom remission                                                                                        
   Combined intervention         3.78 (−1.88; 9.42)       0.185                         5.93 (−0.28; −12.15)     0.061
  Biological rhythm regulation                                                                                   
   Combined intervention         −10.89 (−18.84; −2.95)   0.008                         −10.84 (−20.61; −1.07)   0.031

**Abbreviations:** CI, confidence interval; B, baseline.
